Clinical Trial Update: Short Treatment with Omalizumab for Severe Asthma [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating a short course of omalizumab for severe asthma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Xolair (omalizumab) (omalizumab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Asthma | Phase 4 | Status: RECRUITING